Telephone Mystery Shopping and Converting New Patients
Christine Cowley
When Everyone Has “Skin in the Game”
Naren Arulrajah
The Impact of Clascoterone Topical Cream, 1%
Adelaide Hebert, MD
Leon Kircik, MD, FAAD
The Biosimilar Revolution: A Look at the Potential Impact
Collin Blattner, DO
10 Tips for Managing Hidradenitis Suppurativa
Jennifer L. Hsaio, MD
Katrina H. Lee, MD
New Hope for Patients with Onychomycosis
Gilly Regev, PhD
Christopher Miller, PhD
Scott A. Schumaker, DPM, DABPS, DABPM
I Came In Like a Wrecking Ball
Lisa Swanson, MD, FAAD
In-Depth From the Science of Skincare Summit
Ramie A. Fathy, MD
The View from Under the Hood
Neal Bhatia, MD, FAAD
Comorbidities in Immune-mediated Skin Disorders: What’s Coming
Brad Glick, DO, MPH
Neda Ghiam, MD, MHSc
Amit Sharma, MD
The State of AI in Dermatology
Daniel I. Schlessinger, MD
The Biggest Developments in Dermatology: Drs. Tsao and Friedlander Provide Updates at Maui Derm
Hensin Tsao, MD, PhD
Sheila Fallon-Friedlander, MD
Dermatologists Push Back on Wall Street Journal Characterization
Journal Scan of Three Trials for an Rx Option
Linda Stein Gold, MD
Roflumilast Cream, 0.15%, for Atopic Dermatitis
Brianna A. Green, BS
Peter A. Lio, MD
Maximizing Valuation and Outcomes for Practice Owners: A Conversation with Dana Jacoby
Clint Bundy
Dana Jacoby
Loading...
Stay current with the best on medical education
We're glad to see you're enjoying PracticalDermatology… but how about a more personalized experience?
Press cancel to remain on PracticalDermatology. Press the link below or the continue button to keep going.